CDMODutch State to sell share capital of Intra...The State of the Netherlands, and the Dutch Ministry of Health, Welfare and Sport will sell all shares of vaccine maker Intravacc B.V. more ➔
partnershipTay Therapeutics in licensing deal with VY...Tay Therapeutics Ltd announces licencing of its oral BET blocker TayB2 to VYNE Therapeutics Inc as a treatment for immuno-inflammatory and fibrotic disorders. more ➔
Medigene licences CD40L-CD28 costimulatory...German Medigene AG has acquired global rights to the CD40L-CD28 costimulatory switch receptor that modulates the tumour stroma in order to make T-TCR therapies more effective. more ➔
EU to decarbonise aviation sector through...The European Commission has proposed to set binding sustainable aviation fuels (SAF) targets for the aviation sector to incentivise demand for and supply of SAF vs. kerosene. more ➔
Swiss Biotech Report: Sunrise, not sunset,...In 2022, the Swiss biotech industry "continued to demonstrate its resilience, adapting well to geopolitical upheavals and remaining a key driver of innovation for global healthcare". Swiss … more ➔
Novartis in US$465m deal with 3B Pharmaceu...Targeted radiopharmaceuticals maker 3B Pharmaceuticals snaps US$40m upfront in a global exclusive licensing agreement for its FAP-Targeting Peptide Technology. more ➔
partnershipSyngenta partners with BiotalysSyngenta has announced to leverage Biotalys AGROBODY technology platform to expand its biocontrol pipeline. more ➔
Phialogics AG bags pre-seed financingPhialogics AG has got a €600,000 pre-seed financing from German HTGF to validate its approach to rebalance the immune system of people with auto-immune diseases. more ➔
Forbion raises €1.35bn across two fundsEuropean life sciences venture capital company Forbion has raised two oversubscribed funds totalling €1.35 bn. more ➔
Ariceum Therapeutics extends Series A to ...German radiopharmaceuticals developer Ariceum Therapeutics has raised a further €22.75m extension of its €25m Series A financing announced in June 2022. more ➔
